Literature DB >> 19515475

Kidney function and volume progression in unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis or hypoplasia: a case series.

Diane Poster1, Andreas D Kistler, Fabienne Krauer, Jon D Blumenfeld, Hanna Rennert, Dominik Weishaupt, Rudolf P Wüthrich, Andreas L Serra.   

Abstract

BACKGROUND: The occurrence of unilateral autosomal dominant polycystic kidney disease (ADPKD) with absence of the contralateral kidney has been described only rarely in the literature. Whether unilateral ADPKD is associated with faster disease progression is not known. STUDY
DESIGN: Case series. SETTING & PARTICIPANTS: In a prospective cohort of 182 patients with ADPKD, we identified 3 patients with ADPKD and unilateral renal agenesis (2 patients) or severe hypoplasia (1 patient). MEASUREMENTS & OUTCOMES: Genetic analysis of the PKD1 and PKD2 genes was performed for all 3 patients. Serum creatinine levels and kidney volumes based on magnetic resonance imaging were determined twice, with a 6-month interval between measurements. Characteristics of the 3 patients were compared with age- and sex-matched controls from the full cohort.
RESULTS: Genotyping of the 3 patients indicated that each had a different [corrected] mutation in the PKD1 gene that is predicted to cause frameshift and/or truncation of the protein product. [corrected] All 3 patients with unilateral ADPKD had renal volumes and progression rates greater than the mean values of their matched control groups. However, their glomerular filtration rates were well preserved, with estimated single-kidney creatinine clearances much greater than their controls. LIMITATIONS: The number of cases in this study is small and time of follow-up was limited.
CONCLUSIONS: Unilateral renal agenesis or hypoplasia in patients with ADPKD might not be as rare as previously thought. Glomerular filtration rate was preserved despite unilateral renal absence, suggesting that renal compensatory mechanisms are well conserved in patients with ADPKD.

Entities:  

Mesh:

Year:  2009        PMID: 19515475     DOI: 10.1053/j.ajkd.2009.03.020

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  6 in total

1.  The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.

Authors:  Hong Ye; Xiaofang Wang; Megan M Constans; Caroline R Sussman; Fouad T Chebib; María V Irazabal; William F Young; Peter C Harris; Lawrence S Kirschner; Vicente E Torres
Journal:  Am J Physiol Renal Physiol       Date:  2017-06-14

2.  Soluble klotho and autosomal dominant polycystic kidney disease.

Authors:  Ivana Pavik; Philippe Jaeger; Lena Ebner; Diane Poster; Fabienne Krauer; Andreas D Kistler; Katharina Rentsch; Gustav Andreisek; Carsten A Wagner; Olivier Devuyst; Rudolf P Wüthrich; Christoph Schmid; Andreas L Serra
Journal:  Clin J Am Soc Nephrol       Date:  2011-12-22       Impact factor: 8.237

3.  A case of unilateral nephrectomy performed for autosomal dominant polycystic kidney disease with marked unilateral enlargement.

Authors:  Shiho Makabe; Hiroshi Kataoka; Tsunenori Kondo; Kazunari Tanabe; Ken Tsuchiya; Kosaku Nitta; Toshio Mochizuki
Journal:  CEN Case Rep       Date:  2018-01-31

4.  A comparison of the effects of losartan and ramipril on blood pressure, renal volume and progression in polycystic kidney disease: A 5-Year follow-up.

Authors:  S Ulusoy; G Ozkan; P Kosucu; K Kaynar; I Eyuboglu
Journal:  Hippokratia       Date:  2012-04       Impact factor: 0.471

5.  Autosomal dominant polycystic kidney disease with ectopic unilateral multicystic dysplastic kidney.

Authors:  Jing Xu; Dong-Ping Chen; Zhi-Guo Mao; He-Feng Huang; Chen-Ming Xu; Cong-Rong Wang; Wei-Ping Jia; Chang-Lin Mei
Journal:  BMC Nephrol       Date:  2013-02-17       Impact factor: 2.388

6.  Low-dose oral sirolimus and the risk of menstrual-cycle disturbances and ovarian cysts: analysis of the randomized controlled SUISSE ADPKD trial.

Authors:  Matthias Braun; James Young; Cäcilia S Reiner; Diane Poster; Fabienne Krauer; Andreas D Kistler; Paulus Kristanto; Xueqi Wang; Yang Liu; Johannes Loffing; Gustav Andreisek; Arnold von Eckardstein; Oliver Senn; Rudolf P Wüthrich; Andreas L Serra
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.